LUMINEX CORP
LUMINEX CORP
Aktie · US55027E1029 · LMNX · 936597 (XNAS)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - 0,00 % 0,00 % 21,64 %

Firmenprofil zu LUMINEX CORP Aktie

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Unternehmensdaten

Name LUMINEX CORP
Firma Luminex Corporation
Symbol LMNX
Website http://www.luminexcorp.com
Heimatbörse XNAS NASDAQ
WKN 936597
ISIN US55027E1029
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Mr. Nachum Shamir
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 1,3 T
Adresse 12212 Technology Blvd, 512-219-8020, 78727 Austin
IPO Datum 2000-03-30
Dividenden von 'LUMINEX CORP'
Ex-Datum Dividende pro Aktie
16.06.2021 0,10 USD
24.03.2021 0,10 USD
22.12.2020 0,10 USD
23.09.2020 0,09 USD
17.06.2020 0,09 USD
18.03.2020 0,09 USD
18.12.2019 0,09 USD
25.09.2019 0,09 USD
19.06.2019 0,06 USD
20.03.2019 0,06 USD

Ticker Symbole

Name Symbol
NASDAQ LMNX

Weitere Aktien

Investoren die LUMINEX CORP die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
ANSYS INC
ANSYS INC Aktie
AUTODESK INC
AUTODESK INC Aktie
BL FD SELECT.-EQUIT.B
BL FD SELECT.-EQUIT.B Fonds
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
DEKA-BASISSTRAT.RENTEN CF
DEKA-BASISSTRAT.RENTEN CF Fonds
HSBC BANK PLC CON CPN NTS FT100 IDX EU50 26/03/30
HSBC BANK PLC CON CPN NTS FT100 IDX EU50 26/03/30 Anleihe
INCYTE CORP
INCYTE CORP Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
MONDELEZ INTERNATIONAL INC - CLASS A
MONDELEZ INTERNATIONAL INC - CLASS A Aktie
PERKINELMER INC
PERKINELMER INC Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025